NCT04341766

Brief Summary

Clinical thoracic ultrasound plays an important role in the exploration, diagnosis and follow-up of thoracic pathologies. The COVID (Coronavirus Disease) epidemic is leading to a large influx of patients in the emergency department with respiratory disorders. The rapid diagnosis of respiratory disorders in infected patients is important for further management. Chest ultrasound has already demonstrated its value in the diagnosis of pneumonia in the emergency department with superiority over chest X-ray. However, there is little data on the thoracic ultrasound semiology of viral pneumonia in general and of COVID in particular.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

17 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2020

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 1, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 10, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 27, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

July 17, 2020

Status Verified

July 1, 2020

Enrollment Period

2 months

First QC Date

April 1, 2020

Last Update Submit

July 16, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Characteristics of pulmonary ultrasound for Covid-19 patients

    description of ultrasound abnormalities for Covid-19 patients

    Day one

Secondary Outcomes (5)

  • Characteristics of pulmonary ultrasound for Covid-19 patients

    Day 3

  • Characteristics of pulmonary ultrasound for Covid-19 patients

    Day 14

  • Charateristics of pulmonary CT-scan for Covid-19 patients

    Day 1

  • Charateristics of pulmonary CT-scan for Covid-19 patients

    Day 3

  • Charateristics of pulmonary CT-scan for Covid-19 patients

    Day 14

Study Arms (1)

Patient hospitalised with COVID-19 infection

Patients admitted to hospital with proven COVID-19 infection with respiratory signs warranting a chest CT scan

Other: No special intervention

Interventions

No special intervention : Ultrasound data will be collected

Patient hospitalised with COVID-19 infection

Eligibility Criteria

Age18 Years - 105 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient admitted to hospital with proven COVID-19 infection with respiratory signs and who need an hospitalization

You may qualify if:

  • Patients admitted to hospital with proven COVID-19 infection with respiratory signs warranting a chest CT scan

You may not qualify if:

  • Patient not agreeing to have his or her data collected for the study
  • Unconscious patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

CHU Amiens

Amiens, 80054, France

Location

CH de la Côte Basque

Bayonne, 64109, France

Location

CHU Ambroise Paré

Boulogne-Billancourt, 92104, France

Location

CHU Caen

Caen, 14033, France

Location

CHG de Chambery

Chambéry, 73000, France

Location

Centre Hospitalier Intercommunal de Créteil

Créteil, 94000, France

Location

CHU de Limoges

Limoges, 87000, France

Location

APHM - Hopital Nord

Marseille, 13015, France

Location

CHU de Nancy

Nancy, 54035, France

Location

CHU Nîmes

Nîmes, 30029, France

Location

CHR Orléans

Orléans, 45100, France

Location

CHU Cochin

Paris, 75679, France

Location

CHU Poitiers

Poitiers, 86021, France

Location

CHU Rouen

Rouen, 76038, France

Location

CH Saint-Quentin

Saint-Quentin, 02321, France

Location

CHU Larrey - Toulouse

Toulouse, 31059, France

Location

CHU de Tours

Tours, 37000, France

Location

MeSH Terms

Conditions

Pneumonia, ViralCOVID-19

Condition Hierarchy (Ancestors)

PneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesLung DiseasesRespiratory Tract DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus Infections

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 1, 2020

First Posted

April 10, 2020

Study Start

March 31, 2020

Primary Completion

May 27, 2020

Study Completion

June 30, 2020

Last Updated

July 17, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations